Mark Foletta
Director/Board Member at DEXCOM, INC.
Net worth: 9 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph Hagan | M | 55 | 8 years | |
| Bruce Carter | M | 80 | 12 years | |
| Kevin Sayer | M | 66 | 17 years | |
| Steven Altman | M | 62 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 16 years |
| Don Abbey | M | 57 | 8 years | |
| Ian Smith | M | 58 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.
The Financial Executives Institute
| 4 years |
| Douglas Clark | M | 73 | 25 years | |
| Steven Pacelli | M | 53 | 18 years | |
| Caroline Grace | - | - | 2 years | |
| Whitney Laughlin | F | - | - | |
| Christopher Schwartz | M | - | 19 years | |
| Jay Luly | M | 67 | 21 years | |
| Denise Jackson | F | 59 |
Corporate Directors Forum
 Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | 24 years |
| Caroline Grace | F | 55 | 2 years | |
| Jeffrey Knudson | M | 49 | 3 years | |
| William Rastetter | M | 75 | 11 years | |
| Daphne Jones | F | 67 | 6 years | |
| Kris Miller | M | 58 |
The Financial Executives Institute
| - |
| Adrian D. Shelley | M | - |
The Financial Executives Institute
| - |
| Kristine Peterson | F | 64 | 7 years | |
| Jess Roper | M | 59 |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | 13 years |
| Richard Collins | M | 67 | 7 years | |
| Yujiro Hata | M | 49 | 3 years | |
| Barbara Kahn | M | 71 | 13 years | |
| Hugh Rosen | M | 64 | 8 years | |
| Kyle Malady | M | 56 | 4 years | |
| Karen Dahut | F | 60 | 4 years | |
| Rimma Driscoll | F | - | 1 years | |
| Jacob Leach | M | 46 | 20 years | |
| Kathryn J. Collier | F | 56 | 6 years | |
| Jereme Sylvain | M | 44 | 6 years | |
| Girish Dabeesing | M | - |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | - |
| Jennifer Viera | F | - | 1 years | |
| Daniel Penksa | M | 39 | 9 years | |
| Sylvia Trent Adams | M | 58 | 4 years | |
| Jorge Caballero | M | 67 | 3 years | |
| Teri Fontenot | F | 70 | 5 years | |
| Julia Brown | F | 76 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | 18 years |
| Bridgette Heller | F | 62 | 5 years | |
| Jeff Harris | M | 69 | 19 years | |
| Harry J. Cynkus | M | 74 |
The Financial Executives Institute
| - |
| Ken Goldman | M | 73 |
The Financial Executives Institute
| - |
| Eric Topol | M | 69 | 15 years | |
| Pascale Witz | F | 57 | 7 years | |
| Lesley Russell | M | 63 | 8 years | |
| Allen Hagerman | M | 72 |
The Financial Executives Institute
| - |
| Paul Mellett | M | 68 | 21 years | |
| Andrew Balo | M | 76 | 22 years | |
| Nick Augustinos | M | 65 | 15 years | |
| Mark O. Eisele | M | 66 |
The Financial Executives Institute
| - |
| Lisa E. Porter | M | 60 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 12 years |
| Terry Vance | M | 67 | 13 years | |
| J. Donald Payne | M | 68 |
The Financial Executives Institute
| - |
| Craig Whited | M | - |
The Financial Executives Institute
| - |
| Sean Christensen | M | - | - | |
| Joseph P. O'Leary | M | 69 |
The Financial Executives Institute
| - |
| James J. Sheppard | M | - |
The Financial Executives Institute
| - |
| Dale Allen Thatcher | M | 62 |
The Financial Executives Institute
| - |
| James A. Newcomb | M | 77 |
The Financial Executives Institute
| - |
| Joseph Macnow | M | 78 |
The Financial Executives Institute
| - |
| Mark Ruelle | M | 62 |
The Financial Executives Institute
| - |
| Walter Skowronski | M | 75 |
The Financial Executives Institute
| - |
| Keith E. Brauer | M | 75 |
The Financial Executives Institute
| 40 years |
| Aladin Mawani | M | 72 |
The Financial Executives Institute
| - |
| C. Bruce Burton | M | - |
The Financial Executives Institute
| - |
| Randy Reece | M | - | - | |
| Dowd Thomas | M | - |
The Financial Executives Institute
| - |
| John Partington | M | - |
The Financial Executives Institute
| - |
| Kent Blake | M | - |
The Financial Executives Institute
| - |
| Thomas J. Pennison | M | 56 |
The Financial Executives Institute
| - |
| Yat Sun Or | M | 72 | 25 years | |
| Graham Bowen-Ashwin | M | - |
The Financial Executives Institute
| - |
| Brian Schacker | M | - |
The Financial Executives Institute
| - |
| R. Tripeny | M | 65 |
The Financial Executives Institute
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kleanthis Xanthopoulos | M | 66 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 23 years |
| Michael Earley | M | 68 | 14 years | |
| Harry E. Gruber | M | 72 | 13 years | |
| Terrance Gregg | M | 75 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 13 years |
| Susan Salka | F | 59 | 32 years | |
| Ted Greene | M | 81 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 22 years |
| Stelios Papadopoulos | M | 74 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 19 years |
| Paul Grint | M | 66 | 3 years | |
| Timothy Kennedy | M | 66 | 6 years | |
| Dennis Berman | M | 73 | 10 years | |
| David Parkinson | M | 73 | 7 years | |
| Faheem Hasnain | M | 65 | 10 years | |
| Stephen Worland | M | 66 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 10 years |
| David Szekeres | M | 50 | 1 years | |
| Paul Wagner | M | 53 | - | |
| Michael Yang | M | 62 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | - |
| Lori Kunkel | M | 66 | 5 years | |
| Harry Leonhardt | M | 67 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 years |
| Paul Laikind | M | 68 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | 8 years |
| Joe C. Cook | M | 82 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 15 years |
| Ginger Graham | F | 68 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 14 years |
| Brian Scott | M | 55 | 18 years | |
| Lloyd Rowland | M | 67 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 12 years |
| Jonathan Lord | M | 69 | 9 years | |
| Kevin Sun | M | 46 | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
| Switzerland | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Foletta
- Personal Network
